So how’s my “Tech is back” call (and picks of SWKS and CRUS) doing?
On October 8 I wrote “Tech is back” led by fact-based speculation that Apple (AAPL) had asked supplier to increase production of components for the iPhone 11 by 10%. That, obviously, was a good sign for Apple, which is set to announce earnings on October...
Emerson Electric moves gradually higher on private equity speculation
On the surface the creeping improvement in the price of Emerson Electric (EMR) shares seems odd. The company is a powerhouse in process manufacturing–you know industrial automation, industrial control and safety, and the Internet of Things. And those...
Adding Taiwan Semiconductor Manufacturing to JubakAM.com Special Report 10 Long-term Picks for a Short-term Market as Pick #6 and to my long-term 50 Stocks Portfolio
It’s hard to get a handle on exactly how big the market called the Internet of Things will be. Bain Capital sats $520 billion by 2021. McKensey, another consulting company, says $11 trillion by 2021. The huge difference is a result of 1) what these...
Two strikes and it’s time to sell Tyson out of my 50 Stocks Portfolio
Ok, one lawsuit/investigation/class action action against a company is bad news, usually, for a stock. Two, though? Time to say, Move along. Especially when the company in question shows a remarkable ability to keep getting sued for the same practices. Back in April...
McDonald’s announces test of Beyond-Meat-based PLT
We knew this one was coming, right? Today, McDonald’s (MCD) announced that it would begin a test of the PLT, the plant, lettuce and tomato burger, for 12 weeks in 28 restaurants in south-western Ontario. The move mirrors but trails (by six months) the...
Selling Pfizer out of my Dividend Portfolio tomorrow on Dem’s proposed drug-pricing bill
Why introduce legislation that will dead on arrival in the Republican controlled Senate? Because House Speaker Nancy Pelosi and other Democrats know that controlling drug prices is extremely popular with voters. And a proposal that is a serious effort to lower drug...
Barrick Gold at the junction of positive macro and micro trends; raising my target price
It’s by no means a guarantee of gains, but owing shares of a company that is riding the wave of positive macro and micro trends does indeed usually result in solid profits. On the macro side, Barrick Gold has global trends pointing toward toward higher gold...
Riding the Popeye’s chicken sandwich higher; raising target price for Restaurant Brands International
Today I’m raising my target price for Restaurant Brands International (QSR) because I think the new Popeye’s chicken sandwich has legs. A social media storm has accompanied the introduction of a new chicken sandwich at Popeye’s to compete with...
A deep dive into Exxon Mobil financials shows where even the big oil majors are vulnerable
On Monday, August 19, Â I posted a deep dive into the financials at Concho Resources (CXO) to illustrate some of the pressures weighing on the stocks of oil shale producers. Now Exxon Mobil (XOM) is a very different kind of oil company. It’s diversified globally....
Apple sketches in September product launches–will they be enough?
Two big clouds of doubt hover over shares of Apple (AAPL). First, will the continuing U.S.-China trade war take another bite out of Apple’s China revenue? And/Or disrupt Apple’s China supply chain, saddling the company with higher tariffs on its made in...
Step #1 (of 5) to get your portfolio ready for the Next Big One–Special Report update
Last night on my JubakAM.com subscription site I added Step #1 to my Special Report 5 Is Your Portfolio Ready for the Next Big? The post below is a cut and paste of the material I added to the Special Report. I’m posting it separately here to make it accessible...
Nektar’s plunge is a buying opportunity–so I’m adding more to my Volatility Portfolio
What we know about Nektar Therapeutics (NKTR) is pretty clear. On Thursday of last week, August 8, trading in shares of Nektar were halted on news from the company had manufacturing problems that resulted in some patients enrolled in the clinical trials for the...
SolarEdge Technologies hits all time high on earnings beat, raising my target price in my Picks portfolio
Wednesday, August 7, SolarEdge Technologies (SEDG) reported second quarter revenue of $325 million, up 43% from the second quarter of 2018 and ahead of analyst projections of $315.5 million in revenue. Adjusted earnings rose 15% year over year to 94 cents a share,...
Justice Department to step up antitrust scrutiny of Facebook, Alphabet, Amazon and Apple
According to the Wall Street Journal this afternoon, the Justice Department is opening a broad antitrust review into whether dominant technology firms are unlawfully stifling competition. “The new antitrust inquiry is the strongest signal yet of Attorney General...
Market rally today expands on last week’s “Microsoft rally”
Technology stocks drove the market higher today in an expansion of last week’s subdued but important “Microsoft rally” on that company’s earnings. With earnings from Facebook (FB), Alphabet (GOOG), and Amazon (AMZN) on tap on Wednesday and...
Using softness to add more Treasury exposure to Volatility Portfolio–maybe you should be adding Treasuries too
Treasury prices have been a little weak over the last two weeks. As a consequence the Vanguard Intermediate Term Treasury ETF (VGIT) and the Vanguard Short Term Treasury ETF (VGSH), for example, have dropped from highs on June 25 of $66.03 and $60.94, respectively, to...
Adding China Mobile to my 50 Stocks Portfolio
Recently in my Special Report on Disrupted Sectors on the coming 5G disruption to the telecom and Internet space on my subscription JubakAM.com site, I noted that China would be relatively early to roll out 5G capacity and handsets and that because of that timing and...
In the shortish short term does anything matter for U.S. financial markets except for the Fed?
Think about it this way: The bulk of investors and traders believe that the Federal Reserve will cut interest rates at both the July 31 and September 18 central bank meetings. A significant minority believes that the Fed will deliver more than just two 25 basis point...
PepsiCo beats on earnings as usual
Before the open today, July 9, PepsiCo (PEP) announced second quarter earnings ahead of analyst expectations. But with the stock already up 21.69% for 2019 to date, the market shrugged. PepsiCo shares fell 0.62% at the close. PepsiCo has beaten analyst earnings...
Correction: I’m adding DuPont to my 50 Stocks (not Dividend) Portfolio
I’d be willing to be dollars to donuts that U.S. stocks won’t repeat their first half performance–up 17.4% on the Standard & Poor’s 500–in the second half of the year. It’s hard for me to find a catalyst that isn’t...
Adding Palo Alto Networks, #6 in my 10 Best Picks for the Rest of 2019 on JubakAM.com, to my Jubak Picks and Volatility Portfolios tomorrow
Today I made Palo Alto Networks (PANW) the sixth pick in my Special Report 10 Best Picks for the Rest of 2019 on my JubakAM.com subscription site. Tomorrow, June 28, I’ll add these shares to my Jubak Picks Portfolio and my Volatility Portfolio with a target...
Oil rallies on U.S. inventory drawdown, record U.S. exports, slip in U.S. production–and, oh yes, those pesky tensions with Iran
U.S. benchmark West Texas Intermediate crude is now up 10% for the week following on a 2.44% jump in price to $59.24 a barrel today. International benchmark Brent crude gained 1.94% to $66.31 a barrel. Continued tensions between the United States and Iran, of course,...
Raising target price on Tencent Holdings , #4 in my 10 Best Picks for the Next 6 months of 2019 Special Report on JubakAM.com
In my first three picks for my Special Report 10 Best Picks for the Next Six Months of 2019 on my subscription site JubakAM.com I’ve focused on index ETFs that, in my opinion, will ride the big trend of lower interest rates higher in 2019. In other words, these...
$416 billion for seawalls in the United States by 2040–that’s a lot of gravel sales for Vulcan Materials
In the next 20 years spending on seawalls to protect communities could cost as much as the initial investment in the interstate highway system. Total spending to defend against rising ocean levels could run to $416 billion in the next 20 years, according to a report...
Adding Vanguard Short Term Treasury ETF to my Picks Portfolio
Last night I made Vanguard Short Term Treasury ETF (VGSH) the No. 2 pick in my Special Report 10 Best Picks for the Next 6 Months of 2019 on my JubakAM.com subscription site. Today I’m adding it to my Jubak Picks Portfolio on all my sites. I’m calling this...
Apple contemplates moving some production from China–but not back to the United States
President Donald Trump has argued that slapping higher tariffs on Chinese goods exported to the United States would bring jobs back to this country–if China didn’t agree to a new trade deal–as companies moved factories in order to avoid the higher...
Two more oil tankers attacked in Gulf of Oman; here’s how financial assets moved and which might be interesting ahead
For the second time in a month two oil tankers came under attack in international waters near the strategic Strait of Hormuz. One ship, a Japanese-owned tanker carrying methanol, was apparently attacked by limpet bombs attached to its hull or by a mine. The second...
Chip recovery keeps slipping further away, Broadcom says
Today Broadcom (AVGO) cut its annual sales forecast, saying that the U.S.-China trade war will wipe out the rebound in orders that it had predicted for the second half of 2019. Revenue at the chipmaker for fiscal 2019 will be $22.5 billion instead of the $24.5 billion...
Nektar Therapeutics bumps along ahead of August FDA action on new non-addictive opioid
Shares of Nektar Therapeutics (NKTR) have been bumping along between $32 and $34 for two months now, but the company continues to take steps to prepare for the likely August approval of NKTR-181, a new non-addictive opioid. Nektar has formed Inheris Biopharma, a...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!